AWP
CLB icon

Abacus Wealth Partners’s Core Laboratories CLB Stock Holding History

Abacus Wealth Partners’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,695
Closed -$247K – 361
2026
Q1 		$247K Buy
14,695
+182
+1% +$3.26K 0.02% 418
2025
Q4 		$233K Buy
+14,513
New +$216K 0.02% 429

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Abacus Wealth Partners's CLB Position: Q2 2026 in Review

Abacus Wealth Partners sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 14,695 shares — an estimated $247K sold.

Abacus Wealth Partners first reported a position in CLB in Q4 2025 and held it in 2 quarters. The position peaked at $247K in Q1 2026. 187 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Abacus Wealth Partners reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
  • Abacus Wealth Partners sold 14,695 Core Laboratories shares in Q2 2026, an estimated $247K.
  • Abacus Wealth Partners first reported a position in Core Laboratories in Q4 2025 and held it in 2 quarters.
  • Abacus Wealth Partners's Core Laboratories position peaked at $247K in Q1 2026.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Abacus Wealth Partners's 13F filing for Q2 2026, filed 22 Jul 2026.